Tada - interestingly enough I picked up some more shares myself.  Call me crazy.  I was thinking about buying more warrants but if the Covid trial doesn't hit the mark then it could be all over for the warrants.  Given that the shares are so cheap now it seemed to make more sense to stick with those since with BoM2 they will live to see another day if Covid somehow doesn't pan out.

With Hepalink paying half of the BoM2 trial it also means that 1/2 of the patient population will be in China.  That concerned me somewhat because you never know how geo-politics can impact a company that has such a large Chinese investor.  However, the FDA has already approved the substance of the trial protocol so that does provide some counterweight to that particular risk......maybe.

If the Covid trial pans out in a very strong way then there is a greater chance for a buyout scenario in advance of or during the BoM2 trial.....one would think.  Anyway, with the SP in the low 0.50 range and a Covid trial on the near horizon I figured it was worth taking a bit more of a punt on this thing.  Yes, call me crazy.